Going beyond the current study of the inhibitory effects of miR-622 on lung cancer progression owing to HIF-1α reduction, our results suggest a mechanism underlying down-modulation of HIF-1α by miR-622 that then inactivates EMT pathway genes, leading to reduced levels of Snail, β-catenin, and vimentin. This evidence concerns the gene HIF1A and lung cancer.